Literature DB >> 10833507

Regulation of X11L-dependent amyloid precursor protein metabolism by XB51, a novel X11L-binding protein.

D S Lee1, S Tomita, Y Kirino, T Suzuki.   

Abstract

We isolated a cDNA encoding a novel protein, XB51, that interacts with the amino-terminal domain of the neuron-specific X11-like protein (X11L). The protein XB51 inhibited the association of X11L with amyloid precursor protein through a non-competitive mechanism and abolished the suppression of beta-amyloid production by X11L. The majority of XB51 is localized around the nucleus and recovered in 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid (CHAPS) buffer-insoluble fraction when XB51 is expressed in cells. Association of XB51 with X11L changed the intracellular distribution of XB51 and resulted in redistribution of XB51 into the CHAPS buffer-soluble fraction. These observations suggest that XB51, together with X11L, plays an important role in the regulatory system of amyloid precursor protein metabolism and beta-amyloid generation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10833507     DOI: 10.1074/jbc.C000302200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Quantitative assessment of transcriptome differences between brain territories.

Authors:  Michel de Chaldée; Marie-Claude Gaillard; Nicolas Bizat; Jean-Marie Buhler; Olivier Manzoni; Joël Bockaert; Philippe Hantraye; Emmanuel Brouillet; Jean-Marc Elalouf
Journal:  Genome Res       Date:  2003-07       Impact factor: 9.043

2.  X11alpha haploinsufficiency enhances Abeta amyloid deposition in Alzheimer's disease transgenic mice.

Authors:  Inderjeet Saluja; Henry Paulson; Ashwin Gupta; R Scott Turner
Journal:  Neurobiol Dis       Date:  2009-07-23       Impact factor: 5.996

3.  Neuronal calcium-binding proteins 1/2 localize to dorsal root ganglia and excitatory spinal neurons and are regulated by nerve injury.

Authors:  Ming-Dong Zhang; Giuseppe Tortoriello; Brian Hsueh; Raju Tomer; Li Ye; Nicholas Mitsios; Lotta Borgius; Gunnar Grant; Ole Kiehn; Masahiko Watanabe; Mathias Uhlén; Jan Mulder; Karl Deisseroth; Tibor Harkany; Tomas G M Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

4.  Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection.

Authors:  Eva Hedlund; Martin Karlsson; Teresia Osborn; Wesley Ludwig; Ole Isacson
Journal:  Brain       Date:  2010-08       Impact factor: 13.501

5.  XB51 isoforms mediate Alzheimer's beta-amyloid peptide production by X11L (X11-like protein)-dependent and -independent mechanisms.

Authors:  Akio Sumioka; Seiyu Imoto; Ralph N Martins; Yutaka Kirino; Toshiharu Suzuki
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

Review 6.  Regulated proteolysis of APP and ApoE receptors.

Authors:  Hyang-Sook Hoe; G William Rebeck
Journal:  Mol Neurobiol       Date:  2008-04-15       Impact factor: 5.590

7.  X11beta rescues memory and long-term potentiation deficits in Alzheimer's disease APPswe Tg2576 mice.

Authors:  Jacqueline C Mitchell; Belall B Ariff; Darran M Yates; Kwok-Fai Lau; Michael S Perkinton; Boris Rogelj; John D Stephenson; Christopher C J Miller; Declan M McLoughlin
Journal:  Hum Mol Genet       Date:  2009-09-10       Impact factor: 6.150

8.  Maturation of BRI2 generates a specific inhibitor that reduces APP processing at the plasma membrane and in endocytic vesicles.

Authors:  Shuji Matsuda; Yukiko Matsuda; Erik L Snapp; Luciano D'Adamio
Journal:  Neurobiol Aging       Date:  2009-09-12       Impact factor: 4.673

9.  Evidence of linkage and association on chromosome 20 for late-onset Alzheimer disease.

Authors:  Katrina A B Goddard; Jane M Olson; Haydeh Payami; Monique van der Voet; Helena Kuivaniemi; Gerard Tromp
Journal:  Neurogenetics       Date:  2004-03-19       Impact factor: 2.660

10.  NECAB3 Promotes Activation of Hypoxia-inducible factor-1 during Normoxia and Enhances Tumourigenicity of Cancer Cells.

Authors:  Hiroki J Nakaoka; Toshiro Hara; Seiko Yoshino; Akane Kanamori; Yusuke Matsui; Teppei Shimamura; Hiroshi Sato; Yoshinori Murakami; Motoharu Seiki; Takeharu Sakamoto
Journal:  Sci Rep       Date:  2016-03-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.